313 related articles for article (PubMed ID: 32992819)
1. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs.
Moussa Agha D; Rouas R; Najar M; Bouhtit F; Naamane N; Fayyad-Kazan H; Bron D; Meuleman N; Lewalle P; Merimi M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992819
[TBL] [Abstract][Full Text] [Related]
2. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract][Full Text] [Related]
3. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
4. miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells.
Wang X; Feng Y; Zhang P; Chen H; Bai J; Wang F; He A
Cell Biol Int; 2020 Oct; 44(10):2021-2030. PubMed ID: 32543749
[TBL] [Abstract][Full Text] [Related]
5. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1.
Liu H; Wu H; Qin X
Pathol Res Pract; 2019 Oct; 215(10):152554. PubMed ID: 31431298
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
[TBL] [Abstract][Full Text] [Related]
8. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
9. Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemia.
Xia L; Guo H; Wu X; Xu Y; Zhao P; Yan B; Zeng Y; He Y; Chen D; Gale RP; Zhang Y; Zhang X
Theranostics; 2023; 13(4):1289-1301. PubMed ID: 36923527
[No Abstract] [Full Text] [Related]
10. Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction.
Moussa Agha D; Rouas R; Najar M; Bouhtit F; Fayyad-Kazan H; Lagneaux L; Bron D; Meuleman N; Lewalle P; Merimi M
Cells; 2020 Sep; 9(9):. PubMed ID: 32911844
[TBL] [Abstract][Full Text] [Related]
11. Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
Xue Y; Ge Y; Kang M; Wu C; Wang Y; Rong L; Fang Y
BMC Cancer; 2019 Jan; 19(1):109. PubMed ID: 30700251
[TBL] [Abstract][Full Text] [Related]
12. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
[TBL] [Abstract][Full Text] [Related]
13. Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.
Wang W; Wu X; Zheng J; Yin R; Li Y; Wu X; Xu L; Jin Z
Front Immunol; 2023; 14():1315453. PubMed ID: 38292478
[TBL] [Abstract][Full Text] [Related]
14. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
15. Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Lamble AJ; Kosaka Y; Laderas T; Maffit A; Kaempf A; Brady LK; Wang W; Long N; Saultz JN; Mori M; Soong D; LeFave CV; Huang F; Adams H; Loriaux MM; Tognon CE; Lo P; Tyner JW; Fan G; McWeeney SK; Druker BJ; Lind EF
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14331-14341. PubMed ID: 32513686
[TBL] [Abstract][Full Text] [Related]
16. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAs.
Chiodoni C; Cancila V; Renzi TA; Perrone M; Tomirotti AM; Sangaletti S; Botti L; Dugo M; Milani M; Bongiovanni L; Marrale M; Tripodo C; Colombo MP
Cancer Res; 2020 Feb; 80(3):484-498. PubMed ID: 31776132
[TBL] [Abstract][Full Text] [Related]
18. Identification of non-coding RNA regulatory networks in pediatric acute myeloid leukemia reveals circ-0004136 could promote cell proliferation by sponging miR-142.
Yuan DM; Ma J; Fang WB
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9251-9258. PubMed ID: 31773676
[TBL] [Abstract][Full Text] [Related]
19. CD45
Heo SK; Noh EK; Ju LJ; Sung JY; Jeong YK; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Apr; 20(1):285. PubMed ID: 32252668
[TBL] [Abstract][Full Text] [Related]
20. Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.
Kaźmierczak M; Luczak M; Lewandowski K; Handschuh L; Czyż A; Jarmuż M; Gniot M; Michalak M; Figlerowicz M; Komarnicki M
Med Oncol; 2013 Dec; 30(4):725. PubMed ID: 24085543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
